“In the beginning, I said I wouldn't get it.”: Hesitant adoption of the COVID-19 vaccine in remote Alaska between November 2020 and 2021

“In the beginning, I said I wouldn't get it.”: Hesitant adoption of the COVID-19 vaccine in remote Alaska between November 2020 and 2021
复制标题

“一开始,我说我不会接受。”:2020 年 11 月至 2021 年期间,阿拉斯加偏远地区对 COVID-19 疫苗的采用犹豫不决

DOI:
10.1016/j.socscimed.2023.116197
复制
发表时间:
2023
影响因子:
5.4
通讯作者:
Hahn, Micah
Hahn, Micah
中科院分区:
医学2区
文献类型:
--
作者:
Eichelberger, Laura;Hansen, Amanda;Cochran, Patricia;Fried, Ruby;Hahn, Micah

文献摘要

相似文献

在许多地区,疫苗犹豫阻碍了实现足够的COVID-19疫苗接种覆盖率。许多基于大规模调查样本的研究都描述了疫苗拒绝的特征,但很少有深入的定性研究探讨犹豫不决的采用:疫苗接受和拒绝之间的中间地带,以及个人如何根据他们的生活经验跨越这一连续体。在这篇论文中,我们使用了25名生活在阿拉斯加原住民社区的成年人的叙述来描述“犹豫不决的收养者”所进行的复杂决策过程,在我们的研究中,“犹豫不决的收养者”被定义为那些尽管报告犹豫不决,但仍然完成了最初的COVID-19系列的人。受访者的故事有助于说明犹豫不决的采用者的决策过程如何通过与信任的个人,生活经验,观察,情感和个人动机的互动来理解信息。对于大多数犹豫不决的收养者(n = 20,80%)来说,人际交往是帮助他们做出接种疫苗决定的关键。超过一半的受访者(n = 14,56%)描述了与他们信任的人(包括医疗保健提供者,家人,朋友)的对话以及通过专业网络的互动如何使他们感到安全。三分之一的犹豫不决的收养者(n = 7,28%)将他们决定接种疫苗归因于阿拉斯加土著长老的影响,包括他们的知识,个人经历,以及保护他们的愿望。独立研究对大约四分之一的犹豫不决的采用者(n = 6,24%)也很重要,对于这些受访者来说,这是自己收集信息和向他人学习的过程,特别是可以回答他们问题并减轻他们担忧的医疗保健提供者。本文阐述了疫苗决策的暂时性:对于那些犹豫不决的人来说,接受疫苗可能是一个持续的过程,受到个人经验,关系和背景的影响。
Achieving sufficient COVID-19 vaccination coverage has been hindered in many areas by vaccine hesitancy. Many studies based on large survey samples have characterized vaccine refusal, but there are fewer in-depth qualitative studies that explore hesitant adoption: the middle-ground between vaccine acceptance and refusal, and how individuals may move across this continuum depending on their lived experience. For this paper, we use the narratives of 25 adults living in off-road, predominately Alaska Native communities to describe the complex decision-making processes undertaken by‘hesitant adopters’, defined in our study as those who completed their initial COVID-19 series despite reporting hesitancy. Interviewees' stories help illustrate how hesitant adopters' decision-making processes involved making sense of information through interactions with trusted individuals, lived experiences, observations, emotions, and personal motivations. For the majority of these hesitant adopters' (n = 20, 80%) interpersonal interactions were key in helping to make the decision to get vaccinated. Over half of the interviewees (n = 14, 56%) described how conversations with individuals they trusted, including healthcare providers, family, friends, and interactions through their professional network made them feel safe. One third of the hesitant adopters (n = 7, 28%) attributed their decision to get vaccinated based on the influence of Alaska Native Elders including their knowledge, personal experiences, as well as being motivated by the desire to protect them. Independent research was also important to about a quarter of hesitant adopters (n = 6, 24%), and for these interviewees it was the process of gathering information on their own and learning from others, especially healthcare providers who could answer their questions and alleviate their concerns. This paper illustrates the temporality of vaccine decision-making: vaccine acceptance for those who are hesitant may be an ongoing process that is influenced by personal experience, relationships, and context.